Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Korean Patients with Type 2 Diabetes Mellitus in Real-World Clinical Practice.
A Ram HongBo Kyung KooSang Wan KimKa Hee YiMin Kyong MoonPublished in: Diabetes & metabolism journal (2019)
SGLT2 inhibitors can be a suitable option as either add-on or switch therapy for Korean patients with inadequately controlled T2DM.